Cargando…

Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders

The persistence of HIV-1 associated neurocognitive disorders (HAND) in the post-cART era, afflicting between 40 and 70% of HIV-1 seropositive individuals, supports a critical need for the development of adjunctive therapeutic treatments. Selective estrogen receptor β agonists, including S-Equol (SE)...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaurin, Kristen A., Moran, Landhing M., Booze, Rosemarie M., Mactutus, Charles F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266801/
https://www.ncbi.nlm.nih.gov/pubmed/31858373
http://dx.doi.org/10.1007/s11481-019-09900-y